Oddo BHF analyst Maxime Kogge upgraded Aperam to Neutral from Underperform with a EUR 32 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on APEMY:
- Aperam upgraded to Outperform from Neutral at Exane BNP Paribas
- Aperam price target lowered to EUR 30 from EUR 31 at Morgan Stanley
- APEMY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Aperam price target raised to EUR 20 from EUR 19.50 at JPMorgan
- Aperam price target lowered to EUR 25 from EUR 28 at Barclays